Work

Abstract PS5-08-20: A phase III trial evaluating De-escalation of Breast Radiation (DEBRA) following breast-conserving surgery of stage 1, HR+, HER2-, RS ≤18 breast cancer: NRG-BR007

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-08-20

Authors: J. R. White, R. S. Cecchini, E. E. Harris, E. P. Mamounas, J. G. Bazan, D. G. Stover, P. A. Ganz, R. Jagsi, S. J. Anderson, C. Bergom, V. Théberge, M. B. El-Tamer, R. C. Zellars, D. A. Shumway, G. Chen, T. B. Julian, N. Wolmark

Institutions: The University of Kansas Cancer Center, University of Kansas Medical Center, University of Pittsburgh, NRG Oncology, St. Luke's University Health Network, AdventHealth Orlando, AdventHealth, City Of Hope National Medical Center, City of Hope, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, University of California, Los Angeles, Emory University, Winship Cancer Institute, Washington University in St. Louis, CHU de Québec-Université Laval, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Indiana University Health, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), Medical College of Wisconsin, Allegheny Health Network, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, NSABP Foundation

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129572355

Cites:

Cited by:

Related to: